Search

Your search keyword '"Rydzewska, Grażyna"' showing total 117 results

Search Constraints

Start Over You searched for: Author "Rydzewska, Grażyna" Remove constraint Author: "Rydzewska, Grażyna" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
117 results on '"Rydzewska, Grażyna"'

Search Results

1. Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study

2. Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial

3. Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial

5. Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

6. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

7. Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study

8. Gut microbiome dynamics and predictive value in hospitalized COVID-19 patients: a comparative analysis of shallow and deep shotgun sequencing.

9. Recommendations of Polish Cardiac Society expert regarding the use of andexanet alpha in the Polish context. An interdisciplinary protocol

12. Zastosowanie leków roślinnych w chorobach układu pokarmowego - stanowisko ekspertów Polskiego Towarzystwa Fitoterapii - STANFITO - Gastro. Część I.

13. The use of andexanet alpha in the Polish setting: An interdisciplinary protocol Expert consensus statement of the Polish Cardiac Society.

14. Nonsteroidal anti-inflammatory drugs in clinical practice -- are there any new reports?

15. Opieka farmaceutyczna w codziennej praktyce

17. COVID-19 humoral response

20. Diagnostic and therapeutic recommendations on Helicobacter pylori infection. Recommendations of the Working Group of the Polish Society of Gastroenterology

21. Burnout in healthcare – the Emperor’s New Clothes

29. Gastroduodenal neuroendocrine neoplasms including gastrinoma — update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours) [Nowotwory neuroendokrynne żołądka i dwunastnicy z uwzględnieniem gastrinoma — uaktualnione zasady postępowania (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)]

30. Colorectal neuroendocrine neoplasms — update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours) [Nowotwory neuroendokrynne jelita grubego — uaktualnione zasady diagnostyki i leczenia (rekomendowane przez Polską Sieć Guzów Neuroendokrynych)]

31. Neuroendocrine neoplasms of the small intestine and the appendix — update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours) [Nowotwory neuroendokrynne jelita cienkiego i wyrostka robaczkowego — uaktualnione zasady diagnostyki i leczenia (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)]

32. Update of the diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours) [Aktualizacja zaleceń ogólnych dotyczących postępowania diagnostyczno-terapeutycznego w nowotworach neuroendokrynnych układu pokarmowego (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)]

33. Pancreatic neuroendocrine neoplasms — update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours) [Nowotwory neuroendokrynne trzustki — uaktualnione zasady diagnostyki i leczenia (rekomendowane przez Polską Sieć Guzów Neuroendokrynych)]

38. Diagnostic and therapeutic management in gastroesophageal reflux disease: consensus of the Polish Society of Gastroenterology

45. Social Distancing during COVID-19 Pandemic among Inflammatory Bowel Disease Patients

46. Zastosowanie kliniczne probiotyku zawierającego szczep Lactobacillus paracasei CNCM I-1572.

47. Zastosowanie Lactiplantibacillus plantarum 299v w prewencji zakażenia Clostridioides difficile.

48. Nowotwory neuroendokrynne żołądka i dwunastnicy z uwzględnieniem gastrinoma -- uaktualnione zasady postępowania (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych).

49. Rifaximin in gut microbiota modification in acute pancreatitis: 15 years of retrospective clinical study.

50. Preparation for endoscopic examinations in patients with diabetes and hypoglycaemia.

Catalog

Books, media, physical & digital resources